My bookmarksSign up free

Commission Implementing Regulation (EU) 2021/1377 of 19 August 2021 authorising the change of the conditions of use of the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2021/1377 of 19 August 2021 authorising the change of the conditions of use of the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Implementing Regulation (EU) 2021/1377 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

1.   The entry in the Union list of authorised novel foods, as provided for in Article 6 of Regulation (EU) 2015/2283 and included in Implementing Regulation (EU) 2017/2470, referring to the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae, is amended as specified in the Annex to this Regulation. 2.   The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation.

Article 2

1.   Food supplements containing ≤ 8,0 mg astaxanthin intended for the general population which were lawfully placed on the market before the date of entry into force of this Regulation, may be marketed until their date of minimum durability or use by date. 2.   Foods supplements containing ≤ 8,0 mg astaxanthin intended for the general population imported into the Union may be marketed until their date of minimum durability or use by date where the importer of such food can demonstrate that they were dispatched from the third country concerned and were on their way to the Union before the date of entry into force of this Regulation. 3.   The food business operators should provide a notice for the food supplements referred to in paragraph 1 to be displayed at the place of sale informing them that those food supplements should not be consumed by infants, children and adolescents below the age of 14 years.

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In the Annex to Implementing Regulation (EU) 2017/2470, the entry for ‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ in Table 1 (Authorised novel foods) is replaced by the following: ‘ Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements ‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ The labelling of food supplements containing Astaxanthin-rich oleoresin from Haematococcus pluvialis algae shall bear a statement that they should not be consumed by infants, children, and adolescents younger than 14 years.’   Food Supplements as defined in Directive 2002/46/EC, excluding infants, young children, children, and adolescents younger than14 years 40-80 mg/day of oleoresin, resulting in ≤ 8 mg astaxanthin per day

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1249 of 18 June 2025 on the registration of the geographical indication Kaffeost (PDO) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1182 of 17 June 2025 establishing detailed rules on the rescaling of harmonised indices to the common index reference period 2025 pursuant to Regulation (EU) 2016/792 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1183 of 17 June 2025 on the registration of the geographical indication Spišský šípkový lekvár (PDO) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1186 of 17 June 2025 granting a Union authorisation for the single biocidal product exeol air cid 01 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilRegulation (EU) 2025/1214 of the European Parliament and of the Council of 17 June 2025 amending Regulation (EU) 2019/631 to include an additional flexibility as regards the calculation of manufacturers’ compliance with CO2 emission performance standards for new passenger cars and new light commercial vehicles for the calendar years 2025 to 2027 (Text with EEA relevance)Regulation (EU) 2025/1215 of the European Parliament and of the Council of 17 June 2025 amending Regulation (EU) No 575/2013 as regards requirements for securities financing transactions under the net stable funding ratio (Text with EEA relevance)Regulation (EU) 2025/1227 of the European Parliament and of the Council of 17 June 2025 on the modification of customs duties applicable to imports of certain goods originating in or exported from the Russian Federation and the Republic of BelarusCommission Implementing Regulation (EU) 2025/1233 of 17 June 2025 amending for the 347th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCommission Implementing Regulation (EU) 2025/1171 of 16 June 2025 granting a Union authorisation for the biocidal product family PRODHYNET’s Lactic acid based products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1177 of 16 June 2025 approving the active substance lysate of Willaertia magna as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2025/1220 of 16 June 2025 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2025/1221 of 16 June 2025 concerning the classification of certain goods in the Combined Nomenclature

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next